GenMark Diagnostics, Inc., (NASDAQ: GNMK) announced today that it has
submitted to the U.S. Food and Drug Administration (FDA), for 510(k)
clearance, a Respiratory Viral Panel for use ... read more
GenMark Diagnostics, Inc. (Nasdaq:GNMK) today reported financial
results for the third quarter ended September 30, 2011.
Revenues for the three months ... read more
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to
release its third quarter 2011 earnings results before market open on
Thursday, November 10, 2011. Management will hold ... read more